Meanwhile, according to a 2026 study, patients in the dataset who took Wegovy were 4.74 times more likely to develop ION (Ischemic optic neuropathy) than those who took another brand of GLP-1 drugs
While Semaglutide and Tirzepatide are incredibly effective, they arent the only weight loss tools available
Tirzepatide Withdrawal Data (SURMOUNT-4) After stopping: 14% regained Continuing treatment: maintained nearly all progress Real-world 26-week China follow-up showed 912% regain Even after regain, most participants remained below baseline weight
In ex vivo studies of AD skin biopsies, TRIV-509 significantly reduced epidermal thickness, keratinocyte proliferation, and parakeratosis, while boosting desmoglein-1 expression by over 300%
#Diabetes #GLP1 ggdocs.co/nwlkyc Oohh now I never thought of that not
Histamine-2 receptor antagonists (H2 blockers) such as famotidine represent an intermediate option